Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
3. Bard’s Q4 earnings top estimates
C.R. Bard beat the consensus estimate for its 4th-quarter earnings.
Murray Hill, N.J.-based Bard posted profits of $136.3 million, or $1.79 per share, on sales of $870.8 million for the 3 months ended Dec. 31, 2015, for a bottom-line gain of 1.6% on sales growth of 0.4% compared with Q4 2014. Read more
2. Spectral Medical looks to raise $10m
Spectral Medical said it inked a deal for a $10 million stock sale it plans to use to fund a clinical trial.
Toronto-based Spectral makes a system designed to diagnose and remove endotoxin from the bloodstream. The offering involves the purchase of 14.3 million shares at 70¢ apiece by a consortium of underwriters, who plan to then sell the stock to the public. Read more
1. Wright Medical contests $11m hip verdict
Wright Medical asked a federal judge in Georgia to toss the $11 million verdict from the 1st bellwether trial in the multidistrict litigation filed over its Conserve metal-on-metal hip implant.
An Atlanta jury last year awarded plaintiff Robyn Christiansen $1 million in compensatory damages and another $10 million in punitive damages. The jury found Nov. 24 that the Conserve device was defective and that Wright failed to adequately warn patients about its risks. Read more
The post MassDevice.com +3 | The top 3 medtech stories for January 29, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1QxF2SJ
Cap comentari:
Publica un comentari a l'entrada